[HTML][HTML] Axonal energy metabolism, and the effects in aging and neurodegenerative diseases

S Yang, JH Park, HC Lu - Molecular neurodegeneration, 2023 - Springer
Human studies consistently identify bioenergetic maladaptations in brains upon aging and
neurodegenerative disorders of aging (NDAs), such as Alzheimer's disease, Parkinson's …

[HTML][HTML] Photoreceptor metabolic reprogramming: current understanding and therapeutic implications

WW Pan, TJ Wubben, CG Besirli - Communications biology, 2021 - nature.com
Acquired and inherited retinal disorders are responsible for vision loss in an increasing
proportion of individuals worldwide. Photoreceptor (PR) death is central to the vision loss …

Pharmacological SARM1 inhibition protects axon structure and function in paclitaxel-induced peripheral neuropathy

T Bosanac, RO Hughes, T Engber, R Devraj… - Brain, 2021 - academic.oup.com
Axonal degeneration is an early and ongoing event that causes disability and disease
progression in many neurodegenerative disorders of the peripheral and central nervous …

Structural basis for SARM1 inhibition and activation under energetic stress

M Sporny, J Guez-Haddad, T Khazma, A Yaron… - Elife, 2020 - elifesciences.org
SARM1, an executor of axonal degeneration, displays NADase activity that depletes the key
cellular metabolite, NAD+, in response to nerve injury. The basis of SARM1 inhibition and its …

[HTML][HTML] Constitutively active SARM1 variants that induce neuropathy are enriched in ALS patients

AJ Bloom, X Mao, A Strickland, Y Sasaki… - Molecular …, 2022 - Springer
Background In response to injury, neurons activate a program of organized axon self-
destruction initiated by the NAD+ hydrolase, SARM1. In healthy neurons SARM1 is …

Enrichment of SARM1 alleles encoding variants with constitutively hyperactive NADase in patients with ALS and other motor nerve disorders

J Gilley, O Jackson, M Pipis, MA Estiar, A Al-Chalabi… - Elife, 2021 - elifesciences.org
Enrichment of SARM1 alleles encoding variants with constitutively hyperactive NADase in
patients with ALS and other motor nerve Page 1 Gilley et al. eLife 2021;10:e70905. DOI …

Live imaging reveals the cellular events downstream of SARM1 activation

KW Ko, L Devault, Y Sasaki, J Milbrandt, A DiAntonio - Elife, 2021 - elifesciences.org
SARM1 is an inducible NAD+ hydrolase that triggers axon loss and neuronal cell death in
the injured and diseased nervous system. While SARM1 activation and enzyme function are …

SARM1 depletion rescues NMNAT1-dependent photoreceptor cell death and retinal degeneration

Y Sasaki, H Kakita, S Kubota, A Sene, TJ Lee, N Ban… - elife, 2020 - elifesciences.org
Leber congenital amaurosis type nine is an autosomal recessive retinopathy caused by
mutations of the NAD+ synthesis enzyme NMNAT1. Despite the ubiquitous expression of …

Probing organoid metabolism using Fluorescence Lifetime Imaging Microscopy (FLIM): The next frontier of drug discovery and disease understanding

M Barroso, MG Monaghan, R Niesner… - Advanced Drug Delivery …, 2023 - Elsevier
Organoid models have been used to address important questions in developmental and
cancer biology, tissue repair, advanced modelling of disease and therapies, among other …

SARM1 is required in human derived sensory neurons for injury-induced and neurotoxic axon degeneration

YH Chen, Y Sasaki, A DiAntonio, J Milbrandt - Experimental neurology, 2021 - Elsevier
Axonal degeneration contributes to the pathogenesis of many neurodegenerative disorders,
motivating efforts to dissect the mechanism of pathological axon loss in order to develop …